Hematopoietic stem cell transplantation in Omenn syndrome: a single-center experience-Reference-Cited by-同舟云学术

Hematopoietic stem cell transplantation in Omenn syndrome: a single-center experience

Published:2005-05-23 Issue:2 Volume:36 Page:107-114
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Mazzolari E,Moshous D,Forino C,De Martiis D,Offer C,Lanfranchi A,Giliani S,Imberti L,Pasic S,Ugazio A G,Porta F,Notarangelo L D

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1705017.pdf

Reference23 articles.

1. Omenn G . Familial reticuloendotheliosis with eosinophilia. N Engl J Med 1965; 273: 427–432.

2. Aleman K, Noordzij JG, de Groot R et al. Reviewing Omenn syndrome. Eur J Pediatr 2001; 160: 718–725.

3. Arbiser JL . Genetic immunodeficiencies: cutaneous manifestations and recent progress. J Am Acad Dermatol 1995; 33: 82–89.

4. Glover MT, Atherton DJ, Levinsky RJ . Syndrome of erythroderma, failure to thrive, and diarrhea in infancy: a manifestation of immunodeficiency. Pediatrics 1988; 81: 66–72.

5. O’Driscoll M, Cerosaletti KM, Girard PM et al. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cells 2001; 8: 1175–1185.

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TH2-driven manifestations of inborn errors of immunity;Journal of Allergy and Clinical Immunology;2024-08

2. Successful bone marrow transplantation in a patient with Omenn syndrome, a rare variant of severe combined immunodeficiency syndrome: A case report;Clinical Case Reports;2024-08

3. Expanding the PRAAS spectrum: De novo mutations of immunoproteasome subunit β-type 10 in six infants with SCID-Omenn syndrome;The American Journal of Human Genetics;2024-04

4. Transplant for non-malignant disorders: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem cell sources and graft engineering;Cytotherapy;2023-05

5. Rare immune diseases paving the road for genome editing-based precision medicine;Frontiers in Genome Editing;2023-02-08